VANGUARD ASSET MANAGEMENT, Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 1680208
London, EC4N 8AF, X0
Position in NBIX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$6,331,424
New position
Shares Held
48,060
first reported quarter
Ownership
0.048%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VANGUARD ASSET MANAGEMENT, Ltd holds $183,088,688 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
766,671 | $90,628,178 | |
| 2 | VTRS |
Viatris Inc
|
1,043,155 | $14,093,024 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,503 | $12,750,848 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
410,453 | $12,362,844 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
449,938 | $10,767,016 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
48,060 | $6,331,424 | |
| 7 | ALKS |
Alkermes plc.
|
136,410 | $4,823,457 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
61,064 | $4,631,704 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,331,424 | 48,060 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||